📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update. (2014)

First Author: Martin MA

Attributed to: Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/clpt.2014.38

PubMed Identifier: 24561393

Publication URI: http://europepmc.org/abstract/MED/24561393

Type: Journal Article/Review

Volume: 95

Parent Publication: Clinical pharmacology and therapeutics

Issue: 5

ISSN: 0009-9236